Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
160 participants
INTERVENTIONAL
2018-02-22
2031-02-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of the study is to understand the different functions of the PPC and especially how the processes of spatial coding of the sensory information influences perception and motor planning.
In this study, the investigator want to explore the sensory motor and the perceptual performance of patients with optic ataxia compared with healthy subjects, using 6 behavioral tests.
Objectify the consequences of PPC impairment (visual-motor and perceptual consequences) on patients' quality of life and autonomy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development of the Effectiveness of Rehabilitation Tools for Neurovisual Disorders in Patients With Posterior Cortical Atrophy
NCT04041089
Movement Error-processes and Sensorimotor Adaptation in Parkinsonian Patient
NCT03371407
Self-motion Perception in Parkinson's Disease
NCT03137238
Relationship Between Dopaminergic Asymmetric Degeneration and Attentional Resources in Parkinson's Disease.
NCT03476668
Action-effect Anticipation in Patients With Parkinson's Disease : A Study of the Sensory Attenuation Marker.
NCT02894333
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experience 1
point targets
In the experiences 1 and 2, the participant needs to point different visual targets (LED) in the dark.
Experience 2
point targets
In the experiences 1 and 2, the participant needs to point different visual targets (LED) in the dark.
Experience 3
tactile stimulation
In the experience 3, a tactile stimulation is applied to the middle finger of the 2 hands. The participant needs to indicate into a microphone when he feels the stimulation.
Experience 4
visual images
Target dots or visual images are presented on a computer screen. The participant is required to point to the targets or to react as soon as possible by pressing a response button when they are detected.
Experience 5
visual images
Target dots or visual images are presented on a computer screen. The participant is required to point to the targets or to react as soon as possible by pressing a response button when they are detected.
Experience 6
visual images
Target dots or visual images are presented on a computer screen. The participant is required to point to the targets or to react as soon as possible by pressing a response button when they are detected.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
point targets
In the experiences 1 and 2, the participant needs to point different visual targets (LED) in the dark.
tactile stimulation
In the experience 3, a tactile stimulation is applied to the middle finger of the 2 hands. The participant needs to indicate into a microphone when he feels the stimulation.
visual images
Target dots or visual images are presented on a computer screen. The participant is required to point to the targets or to react as soon as possible by pressing a response button when they are detected.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* male and female, age from 18 to 75 years included
* normal vision or corrected vision
* covered by social security
* signed written informed consent
Patients:
* neurological injury in posterior parietal cortex supported by a cerebral MRI
* present optic ataxia symptoms Healthy subjects
* no known neurological injury
Exclusion Criteria
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laure PISELLA, PhD
Role: PRINCIPAL_INVESTIGATOR
INSERM U1028 - Impact - CRNL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
U1028 INSERM - CNRS UMR 5292 Equipe ImpAct
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A02562-51
Identifier Type: OTHER
Identifier Source: secondary_id
69HCL17_0341
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.